Zhixiang Zhuang

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer

Jianming Xu, Haiping Jiang, Yueyin Pan et al. · JAMA · 2023 · 357 citations · Full text

Medicine, Oncology, Pharmacology +17

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer

Baohui Han, Qingyu Xiu, Huimin Wang et al. · Journal of Thoracic Oncology · 2011 · 91 citations

Medicine, Oncology, Pharmacology +11

First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial

Lin Shen, Yanqiao Zhang, Ziyu Li et al. · Nature Medicine · 2025 · 81 citations

Medicine, Oncology, Pharmacology +11

Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer

Meiqi Shi, Fangwei Jie, Yuxian Bai et al. · Investigational New Drugs · 2017 · 64 citations

Medicine, Oncology, Pharmacology +14

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Feng Wang, Ming-Ming He, Jian Xiao et al. · Clinical Cancer Research · 2022 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +12